ENCODIA INC — Department of Health and Human Services SBIR Phase I: 300

ENCODIA INC — SBIR Phase I award from Department of Health and Human Services.

Amount
$223,600
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
300
Solicitation
PA16-302
NAICS
Place of performance
MD
Period
2017-09-01 → 2018-08-31

Description

ABSTRACT including UNDERLYING PREMISE and STRATEGY to ENSURE ROBUSTNESS Our premise is that developing a better method for analyzing proteomes is required to take full advantage of the technological breakthroughs that have occurred in the last years in DNA sequencing We believe that the difficulties associated with previous proteome analysis methods can be overcome by using an entirely different approach We propose to test this premise by obtaining affinity reagents to N terminal amino acids that can be used in a new massively parallel method for protein sequencing Our strategy to ensure a robust unbiased and reduced risk approach is to develop in parallel the directed evolution of two protein scaffolds and compare them to commercially available and naturally occurring IgG affinity reagents We have chosen methods that are extremely well established in our lab phage display screening in both bulk and emulsions phage display library construction and affinity maturation The two scaffolds for display include lipocalins and scFv Abs While not discussed in the proposal if there is time remaining or if a specific need arises we may try other scaffolds NARRATIVE and OVERALL IMPACT The overall impact of RNA sequencing and digital counting is significant in biological research But RNA molecule counting can only be used as a surrogate for protein abundance That results in a couple of outstanding problems In many cases there appears to be a limited correlation for RNA levels and protein abundance And RNA abundance gives absolutely no information with regard to post translational modification of proteins that is so important to cell signaling and other biological processes We believe the proposed development of a ProCode system will significantly impact many areas of science just as NextGen sequencing has done for genome analysis There are several components to the proposed system development of the assay including proprietary reagents the focus of this proposal instrumentation and software which includes instrumentation control and bioinformatics This proposal will focus on component the development of the binding reagents needed for the ProCode assay Specifically we will describe the experiments needed to generate the N terminal amino acid NTAA recognizing affinity reagents for use in the ProCode assay